1430. The Hidden Costs of Vancomycin Use During the Treatment of Staphylococcus aureus Bacteremia Concurrent with Acute Hematogenous Osteomyelitis

BACKGROUND: Current guidelines recommend the use of parenteral vancomycin for children with acute hematogenous osteomyelitis and concurrent Staphylococcus aureus bacteremia (SAB) due to Methicillin-Resistant Staphylococcus aureus (MRSA), despite vancomycin’s slow bactericidal activity. This study ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashley. Copley, Lawson, Sanchez, Maria J, Sue, Paul K, Lindsay, Eduardo A, Patel, Karisma, Tareen, Naureen G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808846/
http://dx.doi.org/10.1093/ofid/ofz360.1294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808846/
http://dx.doi.org/10.1093/ofid/ofz360.1294

Ejemplares similares